Abstract
Aortic valve stenosis (AS) is the most common heart valve disease with a prevalence up to 3% of adults over the age of 75 years (Nkomo et al. 2006). One-third of US adults ≥65 years has aortic valve sclerosis and of these at least one-third will develop some degree of AS within 5 years (Faggiano et al. 2003; Otto et al. 1999). The natural history, diagnosis, and cellular mechanisms of this disease process have evolved over the past several decades. Over the last 10 years, the scientific progress in the field of calcific aortic valve stenosis has increased exponentially. A critical discovery in our understanding of calcification as the end-stage pathogenesis of a congenital bicuspid or normal tricuspid aortic valve is the osteogenic process (Rajamannan et al. 2003; Otto 2006; Rosenhek et al. 2000a). Progressive calcification of the leaflets usually leads to severe narrowing of the aortic valve orifice and fibrosis of the left ventricular wall, finally resulting in left ventricular outflow tract obstruction and severe aortic stenosis. After a prolonged asymptomatic period with low morbidity and mortality, the development of the classic triad of symptoms including: angina, syncope, or heart failure marks the critical point in the natural history of aortic valve disease. AS is a progressive disease and without intervening treatment associated with high morbidity and mortality rates within a few years of diagnosis (Horstkotte and Loogen 1988). Survival declines when a patient with AS develops angina or syncope, and is even more limited when the patient develops congestive heart failure. Because AS is a disease of the elderly, it can be difficult to distinguish the gradual decrease in physical functioning attributed to advanced age and multiple co-morbidities such as frailty, lung disease, neurological disease, and symptoms from the worsening AS disease. It is not uncommon that patients will lower their activity level below their symptom threshold, to accommodate to the progressive left ventricular outflow tract obstruction. This chapter will outline the studies in the field of diagnosis and the impact of the evolving science of clinical risk factors for calcific aortic valve disease to further understand the complexity of monitoring this disease process in this patient population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Antonini-Canterin F, Huang G, Cervesato E, Faggiano P, Pavan D, Piazza R, Nicolosi GL. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension. 2003;41(6):1268–72.
Avakian SD, Grinberg M, Ramires JA, Mansur AP. Outcome of adults with asymptomatic severe aortic stenosis. Int J Cardiol. 2008;123(3):322–7.
Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84(9):1044–8.
Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109(19):2302–8.
Bogart DB, Murphy BL, Wong BY, Pugh DM, Dunn MI. Progression of aortic stenosis. Chest. 1979;76(4):391–6.
Bonow RO, Carabello BA, Chatterjee K, de Leon Jr AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith Jr SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1–148.
Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995;25(2):305–10.
Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306–14.
Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode Jr RS. Rate of progression of severity of valvular aortic stenosis in the adult. Am Heart J. 1979;98(6):689–700.
Cowell SJ, Newby DE, Burton J, White A, Northridge DB, Boon NA, Reid J. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol. 2003;58(9):712–6.
Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389–97.
Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J. 1991;12(1):10–4.
Dichtl W, Alber HF, Feuchtner GM, Hintringer F, Reinthaler M, Bartel T, Sussenbacher A, Grander W, Ulmer H, Pachinger O, Muller S. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol. 2008;102(6):743–8.
Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am Heart J. 1996;132(2 Pt 1):408–17.
Faggiano P, Antonini-Canterin F, Erlicher A, Romeo C, Cervesato E, Pavan D, Piazza R, Huang G, Nicolosi GL. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol. 2003;91(1):99–101.
Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316–26.
Harken DE. The surgical treatment of acquired valvular disease. Circulation. 1958;18(1):1–6.
Heuvelman HJ, Van Geldorp MWA, Eijkemans MJC, Rajamannan NM, Bogers AJJC, Roos-Hesselink JW, Takkenberg JJM. Progression of aortic valve stenosis is adults: a systematic review. J Heart Valve Dis. 2012; 21:454–462.
Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(Suppl E):57–64.
Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A. Rate of progression of severity of valvular aortic stenosis. Acta Med Scand. 1983;213(1):51–4.
Lafitte S, Perlant M, Reant P, Serri K, Douard H, Demaria A, Roudaut R. Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr. 2009;10(3):414–9.
Larsen VH, Jensen BS. Spontaneous progression of valvular aortic stenosis. Dan Med Bull. 1985;32(1):69–72.
Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest. 1998;113(4):1109–14.
Lichtenstein SV. Closed heart surgery: back to the future. J Thorac Cardiovasc Surg. 2006;131(5):941–3.
Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J. 2008;29(8):1043–8.
Mohler 3rd ER. Are atherosclerotic processes involved in aortic-valve calcification? Lancet. 2000;356(9229):524–5.
Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F, Rajamannan NM. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49(5):554–61.
Nestico PF, DePace NL, Kimbiris D. Progression of isolated aortic stenosis: analysis of 29 patients having more than 1 cardiac catheterization. Am J Cardiol. 1983;52(8):1054–8.
Ng AS, Holmes Jr DR, Smith HC, Connolly DC, Hynes JK, Ilstrup DM, Danielson GK. Hemodynamic progression of adult valvular aortic stenosis. Cathet Cardiovasc Diagn. 1986;12(3):145–50.
Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ. Smoking and obesity are associated with the progression of aortic stenosis. Am J Geriatr Cardiol. 2001;10(2):86–90.
Nitta M, Takamoto T, Taniguchi K. Progression of aortic stenosis in the elderly detected by noninvasive methods. Bull Tokyo Med Dent Univ. 1988;35(1–2):19–24.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.
Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J. 2005;69(12):1535–9.
Otto CM. Valvular aortic stenosis. Disease severity and timing of intervention. J Am Coll Cardiol. 2006;47(11):2141–51.
Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, Kraft CD, Miyake-Hull CY, Schwaegler RG. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262–70.
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142–7.
Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101(21):2497–502.
Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111(24):3290–5.
Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest. 1993;103(6):1715–9.
Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003;107(17):2181–4.
Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O’Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update. Circulation. 2011;124(16):1783–91.
Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe asymptomatic aortic stenosis. N Engl J Med. 2000a;343:611–7.
Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000b;343(9):611–7.
Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G, Baumgartner H. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J. 2004;25(3):199–205.
Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, Bergler-Klein J, Grimm M, Gabriel H, Maurer G. Natural history of very severe aortic stenosis. Circulation. 2010;121(1):151–6.
Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61–7.
Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.
Rubler S, King ML, Tarkoff DM, Dolgin M, Reitano J, Schreiber J. The role of aortic valve calcium in the detection of aortic stenosis: an echocardiographic study. Am Heart J. 1985;109(5 Pt 1):1049–58.
Sanchez PL, Santos JL, Kaski JC, Cruz I, Arribas A, Villacorta E, Cascon M, Palacios IF, Martin-Luengo C. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol. 2006;97(1):90–3.
Shumacker Jr HB. The evolution of cardiac surgery. Bloomington: Indiana University Press; 1992.
Skolnick AH, Osranek M, Formica P, Kronzon I. Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol. 2009;104(1):122–4.
Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8(5):471–83.
Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.
van der Linde D, Yap SC, van Dijk AP, Budts W, Pieper PG, van der Burgh PH, Mulder BJ, Witsenburg M, Cuypers JA, Lindemans J, Takkenberg JJ, Roos-Hesselink JW. Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial). Am J Cardiol. 2011;108(2):265–71.
Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82(6):2111–5.
Wagner S, Selzer A. Patterns of progression of aortic stenosis: a longitudinal hemodynamic study. Circulation. 1982;65(4):709–12.
Wongpraparut N, Apiyasawat S, Crespo G, Yazdani K, Jacobs LE, Kotler MN. Determinants of progression of aortic stenosis in patients aged > or =40 years. Am J Cardiol. 2002;89(3):350–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Heuvelman, H.J., Rajamannan, N.M., Takkenberg, J.J.M. (2013). Modifying the Natural History of Aortic Valve Stenosis. In: Rajamannan, N. (eds) Cardiac Valvular Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-4132-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4132-7_1
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4131-0
Online ISBN: 978-1-4471-4132-7
eBook Packages: MedicineMedicine (R0)